Aktuelle Synthetische und Systembiologie
Offener Zugang

Abstrakt

Bioreactors in Translational Medicine and Drug Development

Amnie Kammoun

Translational medicine aims to accelerate the translation of basic scientific findings into tangible clinical benefits for patients. At the heart of this endeavour lies the need for robust and reliable methods to evaluate therapeutic candidates, understand disease mechanisms, and optimize treatment strategies. Bioreactors, specialized devices designed to support the growth and function of cells or microorganisms in controlled environments, provide invaluable tools for achieving these objectives. By imitating physiological conditions and enabling the scalable production of biologics, bioreactors facilitate the transition of promising therapies from bench to bedside.